Coherus Oncology to Participate in Upcoming Investor Conferences Feb 23, 2026 09:30AM
Coherus Oncology completes $50.1 million stock offering Feb 17, 2026 04:12PM
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock Feb 17, 2026 04:11PM
Coherus Oncology prices $50.1 million stock offering at $1.75 per share Feb 12, 2026 09:18PM
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock Feb 12, 2026 09:18PM


Feb 12, 2026 04:05PM Coherus announces proposed public offering of common stock
Feb 12, 2026 04:05PM Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
May 1, 2025 05:04PM Coherus to Participate in Upcoming Investor Conferences
Feb 24, 2025 09:08AM Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference
Oct 7, 2024 09:22AM TD Cowen Reiterates Buy Rating on Coherus Biosciences (CHRS)
May 30, 2024 02:12PM TD Cowen Reiterates Buy Rating on Coherus Biosciences (CHRS)
May 23, 2024 09:00AM Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
Sep 12, 2023 06:14AM Coherus BioSciences (CHRS) Increases ATM Offering Program by $28.75M
Mar 1, 2023 08:25AM Coherus BioSciences to Present at Upcoming Investor Conferences in March
Mar 4, 2022 04:05PM Coherus Management to Present at Upcoming Investor Conferences
Feb 25, 2021 08:45AM Coherus Management to Present at Upcoming Investor Conferences
Feb 26, 2020 09:30AM Coherus BioSciences Management to Present at the 40th Annual Cowen Healthcare Conference
Apr 8, 2019 09:26AM Pre-Open Stock Movers 04/08: (CHRS) (NBEV) (SNAP) Higher; (ROKU) (GE) (BA) Lower (more...)
Feb 26, 2019 09:30AM Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
Nov 9, 2018 09:05AM Coherus Biosciences (CHRS) PT Lowered to $35 at Cowen
Mar 1, 2018 09:00AM Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
Sep 7, 2017 01:46PM IPR Decision Disappointing for Coherus Biosciences (CHRS) But Focus Remains on Neulasta - Cowen
Jun 12, 2017 12:29PM Coherus Biosciences (CHRS) Neulasta Biosimilar Delay 'Appears Resolvable' - Cowen
Mar 13, 2017 04:01PM Coherus BioSciences Reports Fourth Quarter and Full Year 2016 Corporate Highlights and Financial Results
Mar 1, 2017 09:00AM Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
Feb 8, 2017 08:32AM Coherus BioSciences (CHRS) Prices 5.15M Shares at $24.25
Feb 8, 2017 08:30AM Coherus Prices Public Offering of Common Stock
Feb 7, 2017 04:05PM Coherus BioSciences (CHRS) Commences $125M Offering of Common Stock
Feb 7, 2017 04:04PM Coherus Announces Proposed Public Offering of Common Stock
Feb 26, 2016 09:30AM Coherus BioSciences to Present at Cowen and Company Healthcare Conference on March 8
Apr 1, 2015 05:55AM Coherus BioSciences (CHRS) Prices Larger 4.14M Common Offering at $29/Share
Mar 31, 2015 09:50PM Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock
Mar 31, 2015 09:50PM Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock
Mar 30, 2015 04:02PM Coherus BioSciences (CHRS) to Offer $100M in Common Stock
Mar 30, 2015 04:01PM Coherus Announces Proposed Public Offering of Common Stock
Mar 30, 2015 04:01PM Coherus Announces Proposed Public Offering of Common Stock
Feb 23, 2015 06:00PM Coherus BioSciences to Present at Cowen and Company Health Care Conference on March 2
Dec 1, 2014 09:02AM Cowen Starts Coherus Biosciences (CHRS) at Outperform
Nov 12, 2014 06:59PM Coherus BioSciences Announces Closing of Initial Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares
Nov 6, 2014 12:00PM Coherus BioSciences (CHRS) IPO Opens Lower
Nov 6, 2014 11:52AM Coherus BioSciences Prices Initial Public Offering of $85 Million of Common Stock